The trademark application QUINVERA was filed by GlaxoSmithKline Biologicals S.A., a corporation established under the laws of the Kingdom of Belgium (the "Applicant"). The application was published for oppositions on April 2, 2013, and it was registered by office on July 10, 2013 without any oppositions.
The application was filed in English (German was selected as the second language).
The renewal of the trademark was recorded by the office on December 1, 2022.
A transfer of the trademark registration was recorded on April 20, 2015. Appointment and Replacement of representative of the trademark registration was recorded on July 15, 2015. Appointment and Replacement of representative of the trademark registration was recorded on May 25, 2016. Deletion of the representative of the trademark registration was recorded on January 6, 2021. Appointment and Replacement of representative of the trademark registration was recorded on February 22, 2021.